Elanco to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
19 12월 2023 - 10:00PM
Business Wire
Elanco Animal Health Incorporated (NYSE: ELAN) will participate
in the 42nd Annual J.P. Morgan Healthcare Conference on January
8-10, 2024. Jeff Simmons, president and CEO, will represent the
company and respond to questions from analysts on Tuesday, January
9, 2024 at 3:00 p.m. PST (6:00 PM EST).
A live audio webcast will be available in the “Events and
Presentations” section of Elanco’s investor website. A replay will
be available for approximately 30 days.
ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global
leader in animal health dedicated to innovating and delivering
products and services to prevent and treat disease in farm animals
and pets, creating value for farmers, pet owners, veterinarians,
stakeholders and society as a whole. With nearly 70 years of animal
health heritage, we are committed to helping our customers improve
the health of animals in their care, while also making a meaningful
impact on our local and global communities. At Elanco, we are
driven by our vision of Food and Companionship Enriching Life and
our Elanco Healthy Purpose– all to advance the health of animals,
people, the planet and our enterprise. Learn more at
www.elanco.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231219959132/en/
Investor Contact: Katy Grissom (317) 273-9248
kathryn.grissom@elancoah.com Media Contact: Colleen Parr Dekker
(317) 989-7011 colleen_parr_dekker@elancoah.com
Elanco Animal Health (NYSE:ELAN)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Elanco Animal Health (NYSE:ELAN)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
